You have 9 free searches left this month | for more free features.

B-cell malignancy

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alopecia Areata, Alopecia Totalis, Alopecia Universalis Trial in New Haven, Hackensack (Stem Cell Educator therapy combined with

Not yet recruiting
  • Alopecia Areata
  • +2 more
  • Stem Cell Educator therapy combined with minoxidil
  • New Haven, Connecticut
  • +1 more
Jun 25, 2021

Advanced Solid Tumor Trial (HEC169096)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Jul 6, 2022

Metastatic Carcinoma in the Adrenal Cortex, Stage III Adrenal Cortex Carcinoma AJCC v8, Stage IV Adrenal Cortex Carcinoma AJCC

Active, not recruiting
  • Metastatic Carcinoma in the Adrenal Cortex
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 12, 2022

Nutrition Poor Trial (Awareness campaign - communications campaign, Online shopping)

Not yet recruiting
  • Nutrition Poor
  • Awareness campaign - communications campaign
  • Online shopping
  • (no location specified)
Nov 7, 2022

Cardiovascular Diseases, Acute Coronary Syndrome, Depression Trial in Boston (Adapted MBCT, Cardiac Health Enhancement)

Active, not recruiting
  • Cardiovascular Diseases
  • +2 more
  • Adapted MBCT
  • Cardiac Health Enhancement
  • Boston, Massachusetts
    Mongan Institute: Health Policy Research Center
Nov 9, 2022

NSCLC ALK-positive, NSCLC c-Met Dependent, NSCLC ROS Marker Positive Trial in Worldwide (PF-02341066, Rifampin, Itraconazole)

Completed
  • Non-Small Cell Lung Cancer ALK-positive
  • +4 more
  • Orange, California
  • +28 more
Feb 15, 2022

HIV-1 Infection Trial in Chapel Hill (VRC07-523LS, Vorinostat (VOR))

Completed
  • HIV-1 Infection
  • VRC07-523LS
  • Vorinostat (VOR)
  • Chapel Hill, North Carolina
    University of North Carolina Health Care
Nov 4, 2021

NSCLC, Stage I Trial in Tianjin (Osimertinib)

Recruiting
  • NSCLC, Stage I
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Jan 6, 2023

Langerhan's Cell Histiocytosis, Juvenile Xanthogranuloma, Erdheim-Chester Disease Trial in Memphis, Houston (Cobimetinib)

Recruiting
  • Langerhan's Cell Histiocytosis
  • +6 more
  • Phoenix, Arizona
  • +6 more
Jan 12, 2023

Pulmonary Disease Among Systemic Lupus Erythematosus

Enrolling by invitation
  • Lupus Erythematosus, Systemic
  • Pulmonary Disease
  • Multidisciplinary discussion
  • Odense, Region Southern Denmark, Denmark
    Odense University Hospital
Oct 11, 2023

Hereditary Hemochromatosis, Hyperferritinemia Trial in Basel, Berne (Venipuncture)

Enrolling by invitation
  • Hereditary Hemochromatosis
  • Hyperferritinemia
  • Venipuncture
  • Basel, Switzerland
  • +1 more
Feb 14, 2023

Bacterial Infection, Benign Tumor, Malignant Tumor Trial in Canada, Puerto Rico, United States (Chlorhexidine Gluconate Skin

Completed
  • Bacterial Infection
  • +6 more
  • Chlorhexidine Gluconate Skin Cleanser
  • +3 more
  • Duarte, California
  • +58 more
Jun 18, 2021

Bone Marrow Transplant Complications, Fatigue, Vital Signs Trial in Ankara (Reiki)

Recruiting
  • Bone Marrow Transplant Complications
  • +3 more
  • Reiki
  • Ankara, None Selected, Turkey
    Nursemin Ünal
Jan 19, 2023

Effect of Different Types of Aerobic Training on Diastolic Heart Failure Patients Trial in Bani Suwayf (aerobic exercise for

Completed
  • Effect of Different Types of Aerobic Training on Diastolic Heart Failure Patients
  • aerobic exercise for upper limb
  • aerobic exercise for lower limb
  • Banī Suwayf, Sharq, Egypt
    Beni-Suef University
Nov 24, 2022

GVHD (GvHD) Trial in Cardiff (Thymoglobulin, Cyclophosphamide, Cyclosporine)

Recruiting
  • Graft Versus Host Disease (GvHD)
  • Cardiff, Wales, United Kingdom
    University Hospital of Wales
May 10, 2021

Shingles, Herpes Zoster Infection, Human Trial (Candidate 1: PF-07915234: VZV modRNA Powder for Suspension for Injection,

Not yet recruiting
  • Shingles
  • +2 more
  • Candidate 1: PF-07915234: VZV modRNA Powder for Suspension for Injection
  • +6 more
  • (no location specified)
Jan 19, 2023

Tumors, Tumor Metastasis, Triple Negative Breast Tumors Trial in Edmonton, Montreal (LY3295668)

Completed
  • Neoplasms
  • +6 more
  • Edmonton, Alberta, Canada
  • +2 more
Jun 29, 2021

Squamous Cell Carcinoma of the Head and Neck, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Boston (Interleukin-15

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Interleukin-15 Superagonist (N-803)
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 2, 2022

Acute Myeloid Leukemia Trial in Memphis (Venetoclax, Azacitidine, Cytarabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jul 21, 2023

Diabetes, Type 2, Insulin Resistance Trial in Pécs (Passive heating, Thermoneutral)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Insulin Resistance
  • Passive heating
  • Thermoneutral
  • Pécs, Hungary
    Institute for Translational Medicine, University of Pécs
Feb 8, 2022

Renal Cell Carcinoma Trial in Philadelphia (drug, genetic, other, procedure)

Terminated
  • Renal Cell Carcinoma
  • Brivanib alaninate
  • +5 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Mar 18, 2021

Precision Medicine for Stem Cell Transplantation

Not yet recruiting
  • Haematopoietic Stem Cell Transplantation
  • Blood sample collection
  • Bone marrow aspirate
  • (no location specified)
Oct 4, 2022

Recurrent Small Cell Lung Carcinoma Trial in Atlanta (Durvalumab, Hypofractionated Radiation Therapy, Stereotactic Body

Completed
  • Recurrent Small Cell Lung Carcinoma
  • Durvalumab
  • +3 more
  • Atlanta, Georgia
  • +1 more
May 28, 2021

Anterior Acute Myocardial Infarction, Left Ventricular Systolic Dysfunction Trial in Italy (G-CSF administration)

Terminated
  • Anterior Acute Myocardial Infarction
  • Left Ventricular Systolic Dysfunction
  • G-CSF administration
  • Ancona, AN, Italy
  • +52 more
Feb 2, 2021

Avatrombopag for Thrombocytopenia in Patients Undergoing

Recruiting
  • Thrombocytopenia
  • Shanghai, China
    Zhongshan hospital, Fudan University
Oct 9, 2021